"In 2000, the pharmaceutical industry was, once again, the most profitable U.S. industry, and profit margins in the industry were nearly four times the average of Fortune 500 companies. According to the Families USA report, three companies - Merck, Bristol-Myers Squibb, and Abbott Laboratories - received twice as much in net profits than they spent on research and development. Three other companies - Eli Lilly, Schering-Plough, and Allergan - received more money in net profits than they spent on research and development.
"
- Report from Families USA
| Company | Revenue (Net Sales in millions of dollars) | Profit (Net Income) | Marketing/ Advertising/ Administration | R&D |
| Merck and Co, Inc. | $40,363 | 17% | 15% | 6% |
| Pfizer Inc. | $29,574 | 13% | 39%% | 15% |
| Bristol-Myers Squibb Company | $18,216 | 26% | 30% | 11% |
| Pharmacia Corporation | $18,144 | 4% | 37% | 15% |
| Abbott Laboratories | $13,746 | 20% | 21% | 10% |
| Eli Lilly and Co. | $10,862 | 28% | 30% | 19% |
| Schering-Plough Corporation | $9,815 | 20% | 36% | 14% |
| Allergan, Inc. | $1,563 | 14% | 42% | 13% |